Teva Invests In Expansion In Latin America

BMI View: Multinational drugmakers will increasingly target domestic generic pharmaceutical firms in Latin America, given that such acquisitions provide instant market entry, distribution channels and local industry knowledge. We believe that along with the increasing consolidation of this highly fragmented market, the region's output of pharmaceutical exports will increase. Local industry strategy is expected remain focused on the generic drug sector, given the high demand for low-cost drugs and the lack of infrastructure for research and development (R&D) of high-technology innovative medicines.

To read the full article, please choose one of the following options: